4.7 Review

Innate and adaptive immune responses towardY nanomedicines

期刊

ACTA PHARMACEUTICA SINICA B
卷 11, 期 4, 页码 852-870

出版社

INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2021.02.022

关键词

Cancer immunotherapy; mRNA vaccine; Complement activation; Macrophage; In vivo clearance; Anti-PEG antibody; Nanoparticle; mRNA-1273; BNT162b2; Immunology

资金

  1. Natural Sciences and Engineering Research Council of Canada
  2. Canada Foundation for Innovation
  3. Fondation du CHU de Quebec

向作者/读者索取更多资源

Significant progress has been made in the field of nanomedicine, allowing for more efficient drug delivery and recognition of therapeutic effects through a collaboration of engineering and medicine. Successes in gene silencing methods beyond oncology have paved the way for new therapies. The global pandemic has highlighted the potential of mRNA vaccines, emphasizing the need for rational design of therapies and vaccines in the future.
Since the commercialization of the first liposomes used for drug delivery, Doxil/Caelyx (R) and Myocet (R), tremendous progress has been made in understanding interactions between nanomedicines and biological systems. Fundamental work at the interface of engineering and medicine has allowed nanomedicines to deliver therapeutic small molecules and nucleic acids more efficiently. While nanomedicines are used in oncology for immunotherapy or to deliver combinations of cytotoxics, the clinical successes of gene silencing approaches like patisiran lipid complexes (Onpattro (R)) have paved the way for a variety of therapies beyond cancer. In parallel, the global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has highlighted the potential of mRNA vaccines to develop immunization strategies at unprecedented speed. To rationally design therapeutic and vaccines, chemists, materials scientists, and drug delivery experts need to better understand how nanotechnologies interact with the immune system. This review presents a comprehensive overview of the innate and adaptative immune systems and emphasizes the intricate mechanisms through which nanomedicines interact with these biological functions. (C) 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据